Viewing nowCozalatan Tablet 50 mg (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

MFDS item code 200500820 · Notified 2005.03.28 · Insurance code 656000950
Treatment of hypertension and kidney disease in patients with type 2 diabetes and hypertension
This medication is used to treat hypertension. It also helps to slow the progression of kidney disease in patients with type 2 diabetes who have hypertension. Therefore, it is effective in improving cardiovascular and kidney health associated with hypertension.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension - Adults: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after the start of treatment. If the therapeutic effect is insufficient, the same dose may be given orally in 2 divided doses per day or, if necessary, increased to 100 mg once daily. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose of this medicine is 50 mg once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). Hypertension: If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with other antihypertensive agents (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Elderly patients: No adjustment of the initial dose is necessary in patients 75 years of age or younger. For patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Patients with renal impairment - Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Patients with renal impairment - Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. Patients with decreased intravascular effective blood volume: An initial dose of 25 mg of this medicine once daily is recommended for patients who may have decreased intravascular volume (e.g., patients being treated with diuretics) (see the Precautions for Use section). Patients with hepatic impairment: A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents 6 years of age or older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents 6 years of age or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients with hypersensitivity to this medication or those who are pregnant, patients with severe liver disease, patients with hereditary angioedema, and patients with primary hyperaldosteronism should avoid taking it. Elderly patients, patients with weakened kidney function, patients with hyperkalemia, and patients with heart disease should take this medication with caution and should frequently monitor their condition under the guidance of a physician while taking it. When taking this medication, symptoms may occur due to dizziness or a drop in blood pressure, so caution is necessary while driving or operating machinery. During treatment, blood pressure, kidney function, and electrolyte levels should be regularly monitored for abnormalities. This medication may increase the risk of hyperkalemia when taken in conjunction with potassium-sparing diuretics or potassium supplements, so do not combine it without consulting a physician. Various side effects such as angioedema, liver function abnormalities, muscle pain, and dry cough may also occur, so if symptoms are severe or persistent, notify your healthcare provider immediately. Pregnant or nursing women should preferably avoid taking this medication, and if they must take it, they should discuss it thoroughly with a specialist. Children, especially those under 6 years of age or those with severely reduced kidney function, should not take this medication. In case of overdose, symptoms such as hypotension and cardiac arrhythmias may occur, requiring immediate medical attention for appropriate treatment. It is advisable to avoid consuming grapefruit juice while taking this medication, and be sure to inform your healthcare provider about any other medications you are taking due to potential interactions with other drugs.
Not everyone experiences these, and they can vary from person to person.
This medication is susceptible to air and moisture, so it must be stored in a tightly closed container. It is best to maintain storage temperatures between 1 degree and 30 degrees Celsius to ensure the efficacy and safety of the medication over time.
White oval film-coated tablets
30 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.